Vickers, A. J.;Cronin, A. M.;Roobol, M. J.;Hugosson, J.;Jones, J. S.;Kattan, M. W.;Klein, E.;Hamdy, F.;Neal, D.;Donovan, J.;Parekh, D. J.;Ankerst, D.;Bartsch, G.;Klocker, H.;Horninger, W.;Benchikh, A.;Salama, G.;Villers, A.;Freedland, S. J.;Moreira, D. M.;Schroeder, F. H.;Lilja, H.
The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group
Clinical Cancer Research
2010
16
17
Sep
4374--4381

Liang, Y.;Ankerst, D. P.;Sanchez, M.;Leach, R. J.;Thompson, I. M.
Body mass index adjusted prostate-specific antigen and its application for prostate cancer screening
Urology
2010
76
5
Nov
1268.e1-1268.e6

Horster, S.;Laubender, R. P.;Lehmeyer, L.;Ankerst, D. P.;Eberle, J.;Reinert, R.;Imoehl, M.;van der Linden, M.;Schweiger, B.;Bogner, J. R.
Influence of antiretroviral therapy on immunogenicity of simultaneous vaccinations against influenza, pneumococcal disease and hepatitis A and B in human immunodeficiency virus positive individuals
Journal of Infection
2010
61
6
Dec
484--491

Thompson, IM; Ankerst, DP; Tangen, CM
Prostate-Specific Antigen, Risk Factors, and Prostate Cancer: Confounders Nestled in an Enigma
Journal of the National Cancer Institute
2010
102
17
1299 - 1301